搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Nitrosococcus oceani NADH-quinone oxidoreductase subunit K (nuoK), partial CSB-YP663167NAAI1
CSB-EP663167NAAI1
CSB-BP663167NAAI1
CSB-MP663167NAAI1
CSB-EP663167NAAI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani N-acetyl-gamma-glutamyl-phosphate reductase (argC) CSB-YP663168NAAI
CSB-EP663168NAAI
CSB-BP663168NAAI
CSB-MP663168NAAI
CSB-EP663168NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani 3-isopropylmalate dehydrogenase (leuB) CSB-YP663169NAAI
CSB-EP663169NAAI
CSB-BP663169NAAI
CSB-MP663169NAAI
CSB-EP663169NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Alanine--tRNA ligase (alaS), partial CSB-YP663170NAAI
CSB-EP663170NAAI
CSB-BP663170NAAI
CSB-MP663170NAAI
CSB-EP663170NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Glucose-6-phosphate isomerase (pgi), partial CSB-YP663171NAAI
CSB-EP663171NAAI
CSB-BP663171NAAI
CSB-MP663171NAAI
CSB-EP663171NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Siroheme synthase (cysG) CSB-YP663172NAAI
CSB-EP663172NAAI
CSB-BP663172NAAI
CSB-MP663172NAAI
CSB-EP663172NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani GTPase Der (der) CSB-YP663173NAAI
CSB-EP663173NAAI
CSB-BP663173NAAI
CSB-MP663173NAAI
CSB-EP663173NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani N utilization substance protein B homolog (nusB) CSB-YP663174NAAI
CSB-EP663174NAAI
CSB-BP663174NAAI
CSB-MP663174NAAI
CSB-EP663174NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani D-tyrosyl-tRNA (Tyr) deacylase (dtd) CSB-YP663175NAAI
CSB-EP663175NAAI
CSB-BP663175NAAI
CSB-MP663175NAAI
CSB-EP663175NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Peptidyl-tRNA hydrolase (pth) CSB-YP663176NAAI
CSB-EP663176NAAI
CSB-BP663176NAAI
CSB-MP663176NAAI
CSB-EP663176NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani UPF0102 protein Noc_0355 (Noc_0355) CSB-YP663177NAAI
CSB-EP663177NAAI
CSB-BP663177NAAI
CSB-MP663177NAAI
CSB-EP663177NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani 3-dehydroquinate synthase (aroB) CSB-YP663178NAAI
CSB-EP663178NAAI
CSB-BP663178NAAI
CSB-MP663178NAAI
CSB-EP663178NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Alanine racemase (alr) CSB-YP663179NAAI
CSB-EP663179NAAI
CSB-BP663179NAAI
CSB-MP663179NAAI
CSB-EP663179NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Cytidylate kinase (cmk) CSB-YP663180NAAI
CSB-EP663180NAAI
CSB-BP663180NAAI
CSB-MP663180NAAI
CSB-EP663180NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP663181NAAI
CSB-EP663181NAAI
CSB-BP663181NAAI
CSB-MP663181NAAI
CSB-EP663181NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Protein-export protein SecB (secB) CSB-YP663182NAAI
CSB-EP663182NAAI
CSB-BP663182NAAI
CSB-MP663182NAAI
CSB-EP663182NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia pseudomallei 60 kDa chaperonin 2 (groL2), partial CSB-YP663183BAAL
CSB-EP663183BAAL
CSB-BP663183BAAL
CSB-MP663183BAAL
CSB-EP663183BAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia pseudomallei L-threonine 3-dehydrogenase (tdh) CSB-YP663184BAAL
CSB-EP663184BAAL
CSB-BP663184BAAL
CSB-MP663184BAAL
CSB-EP663184BAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia pseudomallei 4-hydroxy-2-oxovalerate aldolase (mhpE) CSB-YP663185BAAL
CSB-EP663185BAAL
CSB-BP663185BAAL
CSB-MP663185BAAL
CSB-EP663185BAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia pseudomallei 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP663186BAAL
CSB-EP663186BAAL
CSB-BP663186BAAL
CSB-MP663186BAAL
CSB-EP663186BAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>